Entrada Therapeutics, Inc. (TRDA)
12.58
+0.96
(+8.26%)
USD |
NASDAQ |
Mar 06, 16:00
12.81
+0.23
(+1.83%)
After-Hours: 20:00
Entrada Therapeutics Total Liabilities (Quarterly) : 71.24M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| EyePoint Plc | 57.88M |
| Repligen Corp. | 843.57M |
| Vertex Pharmaceuticals, Inc. | 7.477B |
| Kodiak Sciences, Inc. | 194.38M |
| Arcutis Biotherapeutics, Inc. | 243.49M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 377.38M |
| Shareholders Equity (Quarterly) | 306.13M |
| Debt to Equity Ratio | 0.1664 |
| Current Ratio | 12.53 |
| Net Debt Paydown Yield | 0.53% |